Search Count: 21
 |
Erap1 In Complex With 1-[2-(5-Bromo-7-Fluoro-2-Oxo-2,3-Dihydro-1,3-Benzothiazol-3-Yl)Acetamido]-4,4-Difluorocyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2026-05-06 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, SIN, PO4, EDO, A1JVE |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-05-06
Ligands: ZN, SIN, PO4, EDO, A1JVE
 |
Erap1 In Complex With 1-[2-(6-Bromo-2,2-Difluoro-3-Oxo-3,4-Dihydro-2H-1,4-Benzoxazin-4-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.57 Å Release Date: 2026-04-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, PO4, EDO, A1JVD |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-04-22
Ligands: ZN, PO4, EDO, A1JVD
 |
Erap1 In Complex With 1-[2-(2-Oxo-5-Phenyl-2,3-Dihydro-1,3-Benzoxazol-3-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2026-04-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, MLT, EDO, A1JVG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-04-22
Ligands: ZN, MLT, EDO, A1JVG
 |
Erap1 In Complex With 1-[2-(5-Chloro-2-Oxo-2,3-Dihydro-1,3-Benzothiazol-3-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.45 Å Release Date: 2026-04-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, PO4, EDO, A1JVH |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-04-22
Ligands: ZN, PO4, EDO, A1JVH
 |
Erap1 In Complex With 1-[2-(3-Oxo-6-Phenyl-3,4-Dihydro-2H-1,4-Benzoxazin-4-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.37 Å Release Date: 2026-04-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, PO4, EDO, A1JVF |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-04-22
Ligands: ZN, PO4, EDO, A1JVF
 |
C-Terminal Bromodomain Of Human Brd2 With 5-(1-Benzyl-4-Chloro-1H-Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2024-06-26 Classification: TRANSCRIPTION Ligands: EDO, PE4, A1IBV |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-06-26
Ligands: EDO, PE4, A1IBV
 |
N-Terminal Bromodomain Of Human Brd4 With (5-(4-Chloro-1-((Tetrahydro-2H-Pyran-4-Yl)Methyl)-1H-Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2024-06-26 Classification: TRANSCRIPTION Ligands: EDO, A1IB5 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-06-26
Ligands: EDO, A1IB5
 |
N-Terminal Bromodomain Of Human Brd4 With I-Bet567
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2022-12-14 Classification: TRANSCRIPTION Ligands: AKQ, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-12-14
Ligands: AKQ, EDO
 |
N-Terminal Bromodomain Of Human Brd4 With I-Bet282
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2021-10-13 Classification: TRANSCRIPTION Ligands: EDO, UYK |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-10-13
Ligands: EDO, UYK
 |
N-Terminal Bromodomain Of Human Brd2 With 5-(4-(4-Fluorophenyl)-1H-Imidazol-5-Yl)-1-Methylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.26 Å Release Date: 2020-02-19 Classification: TRANSCRIPTION Ligands: SO4, NUQ, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-02-19
Ligands: SO4, NUQ, EDO
 |
N-Terminal Bromodomain Of Human Brd4 With 1-((1-Acetylpiperidin-4-Yl)Methyl)-2-(4-Hydroxy-3,5-Dimethylphenyl)-N-Methyl-1H-Benzo[D]Imidazole-5-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.48 Å Release Date: 2020-01-15 Classification: TRANSCRIPTION Ligands: NUW, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-01-15
Ligands: NUW, EDO
 |
N-Terminal Bromodomain Of Human Brd4 With 1,3-Dimethyl-5-(1-((Tetrahydro-2H-Pyran-4-Yl)Methyl)-1H-Benzo[D]Imidazol-2-Yl)Pyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2020-01-15 Classification: TRANSCRIPTION Ligands: EDO, NUB |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-01-15
Ligands: EDO, NUB
 |
N-Terminal Bromodomain Of Human Brd4 With 5-(1-(1,3-Dimethoxypropan-2-Yl)-5-Morpholino-1H-Benzo[D]Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2020-01-15 Classification: TRANSCRIPTION Ligands: EDO, NV2 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-01-15
Ligands: EDO, NV2
 |
N-Terminal Bromodomain Of Human Brd4 With 5-(1-(1,3-Dimethoxypropan-2-Yl)-5-Morpholino-1H-Benzo[D]Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2020-01-15 Classification: TRANSCRIPTION Ligands: SO4, NUH, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-01-15
Ligands: SO4, NUH, EDO
 |
Bromodomain Of Human Brd9 With 7-(3,4-Dimethoxyphenyl)-2-(4- Methanesulfonylpiperazine-1-Carbonyl)-5-Methyl-4H,5H-Thieno-3,2-C- Pyridin-4-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2015-04-22 Classification: TRANSCRIPTION Ligands: N1D |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2015-04-22
Ligands: N1D
 |
Bromodomain Of Human Brd9 With 7-(3,4-Dimethoxyphenyl)-N-(1,1-Dioxo-1- Thian-4-Yl)-5-Methyl-4-Oxo-4H,5H-Thieno-3,2-C-Pyridine-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.64 Å Release Date: 2015-04-22 Classification: TRANSCRIPTION Ligands: TVU |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2015-04-22
Ligands: TVU
 |
Bromodomain Of Human Brd9 With N-(1,1-Dioxo-1-Thian-4-Yl)-5-Methyl-4- Oxo-7-3-(Trifluoromethyl)Phenyl-4H,5H-Thieno-3,2-C-Pyridine-2- Carboximidamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.72 Å Release Date: 2015-04-22 Classification: TRANSCRIPTION Ligands: EDO, XZB |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2015-04-22
Ligands: EDO, XZB
 |
Bromodomain Of Human Brd9 With N-(1,1-Dioxo-1-Thian-4-Yl)-5-Ethyl-4- Oxo-7-3-(Trifluoromethyl)Phenyl-4H,5H-Thieno-3,2-C-Pyridine-2- Carboximidamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2015-04-22 Classification: TRANSCRIPTION Ligands: EDO, H1B |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2015-04-22
Ligands: EDO, H1B
 |
N-Terminal Bromodomain Of Human Brd4 With 7-(3,4-Dimethoxyphenyl)-N-(1,1-Dioxo-1-Thian-4-Yl)-5-Methyl-4-Oxo-4H,5H-Thieno-3,2-C-Pyridine-2- Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.58 Å Release Date: 2015-04-22 Classification: TRANSCRIPTION Ligands: CA, EDO, TVU |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2015-04-22
Ligands: CA, EDO, TVU
 |
N-Terminal Bromodomain Of Human Brd4 With N-(1,1-Dioxo-1-Thian-4-Yl)- 5-Methyl-4-Oxo-7-3-(Trifluoromethyl)Phenyl-4H,5H-Thieno-3,2-C- Pyridine-2-Carboximidamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2015-04-22 Classification: TRANSCRIPTION Ligands: EDO, 5V2 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2015-04-22
Ligands: EDO, 5V2